Stereotaxis to Report Third Quarter 2023 Financial Results on November 9, 2023
17 oct. 2023 09h05 HE
|
Stereotaxis, Inc.
ST. LOUIS, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
Stereotaxis Robotic Technology to be Featured during 7th Annual Meeting of the Society for Cardiac Robotic Navigation
04 oct. 2023 08h49 HE
|
Stereotaxis, Inc.
ST. LOUIS, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
Heart Centre Rigshospitalet Enhances Leadership in Patient Care with Adoption of Latest Robotic Technology
06 sept. 2023 08h56 HE
|
Stereotaxis, Inc.
ST. LOUIS, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...
Overland Park Regional Medical Center Becomes First U.S. Hospital with Two Stereotaxis Robotic Systems for Arrhythmia Treatment
30 août 2023 08h49 HE
|
Stereotaxis, Inc.
ST. LOUIS, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...
Live Long-Distance TeleRobotic Procedures to Highlight Stereotaxis Technology at Asia Pacific Heart Rhythm Symposium
16 août 2023 08h40 HE
|
Stereotaxis, Inc.
ST. LOUIS, Aug. 16, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that its...
Stereotaxis Reports 2023 Second Quarter Financial Results
10 août 2023 09h00 HE
|
Stereotaxis, Inc.
ST. LOUIS, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
Stereotaxis and Abbott Combine Technologies in First Integrated Procedures to Treat Arrhythmia Patients
18 juil. 2023 09h18 HE
|
Stereotaxis, Inc.
ST. LOUIS, July 18, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the first...
Stereotaxis to Report Second Quarter 2023 Financial Results on August 10, 2023
17 juil. 2023 06h00 HE
|
Stereotaxis, Inc.
ST. LOUIS, July 17, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
Stereotaxis to Initiate First-in-Human Trial to Support CE Mark Application of MAGiC Catheter
15 juin 2023 16h10 HE
|
Stereotaxis, Inc.
ST. LOUIS, June 15, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it...
Stereotaxis to Participate in 20th Annual Craig-Hallum Institutional Investor Conference
25 mai 2023 08h56 HE
|
Stereotaxis, Inc.
ST. LOUIS, May 25, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David...